Nov 2007: Passion and Determination are Success Drivers for Entrepreneurs




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Nov 2007: Passion and Determination are Success Drivers for Entrepreneurs
Released on: November 01, 2007. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    This Commentary looks at the experience of being a panellist at an Investor Summit in Australia, in which up-and-coming entrepreneurs gave a in 5-minute presentation of their business and investment opportunities to a panel of venture capitalists (VCs), investment bankers and deal makers.
  • Summary
  • Transcript
  • Participants
  • Company
This Commentary looks at the experience of being a panellist at an Investor Summit in Australia, in which up-and-coming entrepreneurs gave a in 5-minute presentation of their business and investment opportunities to a panel of venture capitalists (VCs), investment bankers and deal makers. One of the biggest problems found was that the presenters did not understand who the panellists really were, and what they really needed from the presentations. Also, the majority of those presenting had businesses too early for seed capital, and were urged to go back to their companies and continue to get government or research/university funding. But there was no doubt that some of the presenters had something going for them. Some of the more successful budding entrepreneurs, besides having a strong commercial case and a clear business vision backed up with a realistic business plan, had another important ingredient, and probably one more crucial than anything else – pure passion and determination – an indication of future success!

PharmaDeals Reference: 271

Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.
I was a panellist at an Investor Summit in Australia last week watching up-and-coming entrepreneurs present in 5 minutes their business and investment opportunities. The panellists were made up of venture capitalists (VCs), investment bankers and deal makers. We have all seen presentations over the years by hopefuls wishing to raise finance or complete some form of transaction. Presenting your case in 5 minutes is daunting, even for the most experienced of presenters. Nevertheless, I think it’s a wonderful way to get clarity around a business concept. If you cannot articulate the key messages and vision in that time you have a real problem with yourself and your business. One of the biggest problems at this event was that our presenters did not understand who the panellists really were. They had not researched or thought about them. Worse still, some of the presenters thought that the panellists were just interested in money, they had not realised that we all had strong scientific backgrounds and were in a position to ask cutting questions on the feasibility of, and risks involved in, taking their projects forward. Furthermore, many of the presenters made the mistake of telling the panellists something that they already knew and was common knowledge – such as total market size, which, in the end, is pure non-information to most VCs, who want to know what size of that market the business is going to capture or grow to, and how. They want to know how any investment is going to add value, and what milestone(s) can be achieved. "Some of the more successful budding entrepreneurs, besides having a strong commercial case and a clear business vision backed up with a realistic business plan, had another important ingredient, and probably one more crucial than anything else – pure passion and determination. The majority of those presenting had businesses too early for seed capital, and these were urged to go back to their companies and continue to get government or research/university funding. This was in their best interests because it was non-dilutive from a shareholder perspective, and would allow the research to reach a point at which it was ready for true commercialisation, i.e. sufficiently de-risked and at some stage of basic proof-of-concept. There was no doubt that some of these presenters had something going for them, but others, frankly, did not. Some of the more successful budding entrepreneurs, besides having a strong commercial case and a clear business vision backed up with a realistic business plan, had another important ingredient, and probably one more crucial than anything else – pure passion and determination. These will be the successful ones! -Fintan Walton, Chief Executive Officer, PharmaVentures Ltd.
Archimedes Pharma Ltd
Archimedes is a European specialty pharmaceutical company with an established commercial organisation in the UK, France, Germany, Ireland and Spain and a portfolio of products marketed to specialist prescribers. Archimedes is growing its commercial presence through the acquisition of pharmaceutical companies and brands in Europe, and through partnering with companies to drive sales of their innovative products. In parallel, Archimedes is developing a robust pipeline of novel near and longer-term products to support its commercial organisation.